Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
GSK is seeking a Regulatory Project and Resource Manager to lead end-to-end regulatory planning for a HIV development portfolio. You will translate regulatory strategy into executable development plans, manage timelines, resources and costs, ensuring governance-ready deliverables across Global Regulatory Affairs.
The role emphasizes Planisware planning, scenario analysis, and proactive risk management in a complex matrix environment, partnering with GRLs, RMTs, PPMs, Clinical, Safety, CMC and
This role sits within the Regulatory Excellence function of GSK’s Research & Development (R&D) division, which leads and orchestrates regulatory excellence across Global Regulatory Affairs (GRA) to ensure high-quality, compliant and timely submissions to Health Authorities. The role reports into a Director for Regulatory Operational Excellence, and is aligned to provide expertise to GSK’s HIV medicines portfolio. Job-purpose: The Regulatory Project and Resource Manager (RPRM) provides end-to-end regulatory planning and resource expertise and management for a portfolio of development projects, translating Global Regulatory Strategy into integrated, executable and governance-ready Regulatory Development Plans (RDPs). The role manages planning, resource and cost forecasts, scenario analysis and portfolio insights to support effective regulatory delivery and informed portfolio decision-making.
About You: This role is a great opportunity to be instrumental in developing and delivering GSK’s R&D aims. As this role is multi-faceted and includes collaborating / liaising with a wide variety of stakeholders and matrix teams you must have strong experience of working in complex matrix-environment, with demonstrable clear problem-solving approach to your work and a track‑record of delivery. Strong people skills and a proven ability to influence people to achieve and drive performance are also pre-requisites for this role.
Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most.
Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people. GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law. We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us at UKRecruitment.Adjustments@gsk.com where you can also request a call. Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels.
Application closing date – Friday 30th of October 2026 (COB).
GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together.